Relief Rally, Charting the Indexes, Fed Talk, Taiwan Semi, Musk Bids for Twitter

The market roared, but the pros did not tag along in size. They either have to catch up, or they are just not coming.

A New Big-Cap Buy That Benefits From Higher Interest Rates

My main strategy now is short-term trades and very small incremental buys for the longer term.

Sorry, There Are No Signs That the Market Correction Is Finished

All the indexes are in near-term downtrends -- except for one.

Extreme Negativity Creates Conditions for a Bounce, But How Far Can it Run?

Despite doom and gloom and negative technical patterns, there is positive action early Wednesday.

Is the Market Correction Over?

Here's what charts and data are telling us.

Markets, Russia, China and the Fed

I am more concerned, for markets, about quantitative tightening than rate hikes.

CPI Day, Runaway Inflation, Bond Yields, Trading Microsoft, Nvidia, AMD and More

The march toward positive real yield territory has put the whammy on equities, primarily on tech or "growthy" type stocks that have run at higher valuations.

Bearish Bets: 3 Stocks You Should Consider Shorting This Week

These recently downgraded names are displaying both quantitative and technical deterioration.

BioXcel Therapeutics: Here's Why I'm Buying and How You Can Trade It

After receiving an FDA approval, the small-cap biotech looks well positioned as a covered call candidate.

3 Dividend Stocks for Rising Interest Rates

There are certain sectors of the stock market where rising rates create tailwinds for earnings.